Risk assessment, screening and prevention of breast cancer: A look at cost-effectiveness

被引：9
作者：
Lebovic, Gail S. [1 ]
Hollingsworth, Alan [2 ]
Feig, Stephen A. [3 ]
机构：
[1] Amer Soc Breast Dis, Frisco, TX 75034 USA
[2] Mercy Hlth Ctr, Dept Surg, Mercy Womens Ctr, Oklahoma City, OK 73120 USA
[3] Univ Calif Irvine, Irvine Sch Med, UCI Med Ctr, Orange, CA 92868 USA
来源：
BREAST | 2010年 / 19卷 / 04期
关键词：
Breast cancer; Cost-effectiveness; Mammography; Screening; Risk assessment; Prevention; NIPPLE ASPIRATE FLUID; 20-YEAR FOLLOW-UP; AGED; 40-49; YEARS; EPITHELIAL-CELLS; MAMMOGRAPHY; WOMEN; TAMOXIFEN; TRIAL; GUIDELINES; MORTALITY;
D O I：
10.1016/j.breast.2010.03.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recent suggestions by the United States Preventive Task Force to change the longstanding guidelines for screening mammography have raised the issue of cost-effectiveness in regards to breast cancer detection. Given the enormous number of women who have had, or who will be diagnosed with breast cancer, it is essential to maintain the quality of care that has been achieved here in the United States while utilizing a cost-effective approach. The following review attempts a close examination of current methods available for risk assessment, screening and prevention programs. These programs must be carefully considered and analyzed prior to implementing cost-saving changes to current clinical standards that have proven successful in decreasing the mortality from breast cancer throughout the world. (c) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：260 / 267
页数：8
相关论文
共 38 条
[1]  
[Anonymous], 1996, COST EFFECTIVENESS H, DOI DOI 10.1093/OSO/9780195108248.001.0001
[2]   Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: A historic prospective study [J].
Baltzell, Kimberly A. ;
Moghadassi, Michelle ;
Rice, Terri ;
Sison, Jennette D. ;
Wrensch, Margaret .
BMC CANCER, 2008, 8 (1)
[3]   The effect of changing from one to two views at incident (subsequent) screens in the NHS breast screening programme in England: impact on cancer detection and recall rates [J].
Blanks, RG ;
Bennett, RL ;
Patnick, J ;
Cush, S ;
Davison, C ;
Moss, SM .
CLINICAL RADIOLOGY, 2005, 60 (06) :674-680
[4]  
BROWN ML, 1992, CANCER-AM CANCER SOC, V69, P1963, DOI 10.1002/1097-0142(19920401)69:7+<1963::AID-CNCR2820691717>3.0.CO
[5]  
2-0
[6]   Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: A 25-year prospective study [J].
Buehring, Gertrude Case ;
Letscher, Amy ;
McGirr, Kathleen M. ;
Khandhar, Shruti ;
Che, Lisa H. ;
Nguyen, Christine T. ;
Hackett, Adeline J. .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 98 (01) :63-70
[7]   Breast cancer mortality after screening mammography in British Columbia women [J].
Coldman, Andrew ;
Phillips, Norm ;
Warren, Linda ;
Kan, Lisa .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (05) :1076-1080
[8]   Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk [J].
Cummings, Steven R. ;
Tice, Jeffrey A. ;
Bauer, Scott ;
Browner, Warren S. ;
Cuzick, Jack ;
Ziv, Elad ;
Vogel, Victor ;
Shepherd, John ;
Vachon, Celine ;
Smith-Bindman, Rebecca ;
Kerlikowske, Karla .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (06) :384-398
[9]   Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial [J].
Cuzick, Jack ;
Forbes, John F. ;
Sestak, Ivana ;
Cawthorn, Simon ;
Hamed, Hisham ;
Holli, Kaija ;
Howell, Anthony .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (04) :272-282
[10]   INDUCED COSTS OF LOW-COST SCREENING MAMMOGRAPHY [J].
CYRLAK, D .
RADIOLOGY, 1988, 168 (03) :661-663
1234